{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:23:48Z","timestamp":1785813828428,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,5]]},"DOI":"10.7759\/cureus.24765","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T04:27:33Z","timestamp":1651811253000},"source":"Crossref","is-referenced-by-count":2,"title":["No NLRP3 Inflammasome Expression in the Ouabain Animal Model of Bipolar Disorder"],"prefix":"10.7759","author":[{"given":"Ali A","family":"Farooqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifaat S","family":"El-Mallakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat JD","year":"2014","unstructured":"Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014, 53:23-34. 10.1016\/j.pnpbp.2014.01.013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12414","article-title":"Are medical comorbid conditions of bipolar disorder due to immune dysfunction?","volume":"132","author":"Rosenblat JD","year":"2015","unstructured":"Rosenblat JD, McIntyre RS. Are medical comorbid conditions of bipolar disorder due to immune dysfunction?. Acta Psychiatr Scand. 2015, 132:180-91. 10.1111\/acps.12414","journal-title":"Acta Psychiatr Scand"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2015.09.006","article-title":"Bipolar disorder and inflammation","volume":"39","author":"Rosenblat JD","year":"2016","unstructured":"Rosenblat JD, McIntyre RS. Bipolar disorder and inflammation. Psychiatr Clin North Am. 2016, 39:125-37. 10.1016\/j.psc.2015.09.006","journal-title":"Psychiatr Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105325","article-title":"Inflammation in bipolar disorder (BD): identification of new therapeutic targets","volume":"163","author":"Pereira AC","year":"2021","unstructured":"Pereira AC, Oliveira J, Silva S, Madeira N, Pereira CM, Cruz MT. Inflammation in bipolar disorder (BD): identification of new therapeutic targets. Pharmacol Res. 2021, 163:105325. 10.1016\/j.phrs.2020.105325","journal-title":"Pharmacol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm K","year":"2013","unstructured":"Munkholm K, Bra\u00fcner JV, Kessing LV, Vinberg M. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013, 47:1119-33. 10.1016\/j.jpsychires.2013.05.018","journal-title":"J Psychiatr Res"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)36591-2","article-title":"Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity","volume":"269","author":"Perregaux D","year":"1994","unstructured":"Perregaux D, Gabel CA. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem. 1994, 269:15195-15203.","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-7-23","article-title":"Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes","volume":"7","author":"Bryan NB","year":"2010","unstructured":"Bryan NB, Dorfleutner A, Kramer SJ, Yun C, Rojanasakul Y, Stehlik C. Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes. J Inflamm (Lond). 2010, 7:23. 10.1186\/1476-9255-7-23","journal-title":"J Inflamm (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.3105cm2","article-title":"Interleukin-1beta (IL-1beta) processing pathway","volume":"3","author":"Weber A","year":"2010","unstructured":"Weber A, Wasiliew P, Kracht M. Interleukin-1beta (IL-1beta) processing pathway. Sci Signal. 2010, 3:cm2. 10.1126\/scisignal.3105cm2","journal-title":"Sci Signal"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00742-6","article-title":"Inflammatory signaling mechanisms in bipolar disorder","volume":"28","author":"Jones GH","year":"2021","unstructured":"Jones GH, Vecera CM, Pinjari OF, Machado-Vieira R. Inflammatory signaling mechanisms in bipolar disorder. J Biomed Sci. 2021, 28:45. 10.1186\/s12929-021-00742-6","journal-title":"J Biomed Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2015.10.015","article-title":"Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation","volume":"72","author":"Kim HK","year":"2016","unstructured":"Kim HK, Andreazza AC, Elmi N, Chen W, Young LT. Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation. J Psychiatr Res. 2016, 72:43-50. 10.1016\/j.jpsychires.2015.10.015","journal-title":"J Psychiatr Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/408136","article-title":"The potential role of the NLRP3 inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder","volume":"2015","author":"Kim HK","year":"2015","unstructured":"Kim HK, Chen W, Andreazza AC. The potential role of the NLRP3 inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder. Neural Plast. 2015, 2015:408136. 10.1155\/2015\/408136","journal-title":"Neural Plast"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2003.00053.x","article-title":"Intracerebroventricular administration of ouabain as a model of mania in rats","volume":"5","author":"El-Mallakh RS","year":"2003","unstructured":"El-Mallakh RS, El-Masri MA, Huff MO, Li XP, Decker S, Levy RS. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord. 2003, 5:362-5. 10.1034\/j.1399-5618.2003.00053.x","journal-title":"Bipolar Disord"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0494-6","article-title":"Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives","volume":"9","author":"Valvassori SS","year":"2019","unstructured":"Valvassori SS, Dal-Pont GC, Resende WR, Varela RB, Lopes-Borges J, Cararo JK, Quevedo J. Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives. Transl Psychiatry. 2019, 9:158.","journal-title":"Transl Psychiatry"},{"key":"ref14","article-title":"Animal models of mania","author":"Robbins TW","year":"1980","unstructured":"Robbins TW, Sahakian BJ. Animal models of mania. Mania: An Evolving Concept. Bellmaker RH, Ban Prang HM (ed): Spectrum, New York; 1980. 143-216."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2019.09.016","article-title":"Review of animal models of bipolar disorder that alter ion regulation","volume":"107","author":"Mack AA","year":"2019","unstructured":"Mack AA, Gao Y, Ratajczak MZ, Kakar S, El-Mallakh RS. Review of animal models of bipolar disorder that alter ion regulation. Neurosci Biobehav Rev. 2019, 107:208-14. 10.1016\/j.neubiorev.2019.09.016","journal-title":"Neurosci Biobehav Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/10673220127873","article-title":"Mood stabilizers and ion regulation","volume":"9","author":"El-Mallakh RS","year":"2001","unstructured":"El-Mallakh RS, Huff MO. Mood stabilizers and ion regulation. Harv Rev Psychiatry. 2001, 9:23-32. 10.1080\/10673220127873","journal-title":"Harv Rev Psychiatry"},{"key":"ref17","article-title":"Effect of dopamine on intracellular sodium: a common pathway for pharmacologic mechanism of action in bipolar illness","volume":"11","author":"Roberts RJ","unstructured":"Roberts RJ, Repass R, El-Mallakh RS. Effect of dopamine on intracellular sodium: a common pathway for pharmacologic mechanism of action in bipolar illness. World Journal of Biological Psychiatry. 11:181-167.","journal-title":"World Journal of Biological Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2010.02.002","article-title":"Intracerebroventricular ouabain administration induces oxidative stress in the rat brain","volume":"28","author":"Riegel RE","year":"2010","unstructured":"Riegel RE, Valvassori SS, Moretti M, et al.. Intracerebroventricular ouabain administration induces oxidative stress in the rat brain. Int J Dev Neurosci. 2010, 28:233-7. 10.1016\/j.ijdevneu.2010.02.002","journal-title":"Int J Dev Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2014.09.007","article-title":"Effects of ouabain on cytokine\/chemokine levels in an animal model of mania","volume":"276","author":"Tonin PT","year":"2014","unstructured":"Tonin PT, Valvassori SS, Lopes-Borges J, Mariot E, Varela RB, Teixeira AL, Quevedo J. Effects of ouabain on cytokine\/chemokine levels in an animal model of mania. J Neuroimmunol. 2014, 276:236-9. 10.1016\/j.jneuroim.2014.09.007","journal-title":"J Neuroimmunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2010.12.030","article-title":"Memantine reduces mania-like symptoms in animal models","volume":"188","author":"Gao Y","year":"2011","unstructured":"Gao Y, Payne RS, Schurr A, et al.. Memantine reduces mania-like symptoms in animal models. Psychiatry Res. 2011, 188:366-71. 10.1016\/j.psychres.2010.12.030","journal-title":"Psychiatry Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1471-y","article-title":"A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury","volume":"16","author":"Kuwar R","year":"2019","unstructured":"Kuwar R, Rolfe A, Di L, et al.. A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. J Neuroinflammation. 2019, 16:81. 10.1186\/s12974-019-1471-y","journal-title":"J Neuroinflammation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?","volume":"22","author":"Abais JM","year":"2015","unstructured":"Abais JM, Xia M, Zhang Y, Boini KM, Li PL. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?. Antioxid Redox Signal. 2015, 22:1111-29. 10.1089\/ars.2014.5994","journal-title":"Antioxid Redox Signal"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang Y","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019, 10:128. 10.1038\/s41419-019-1413-8","journal-title":"Cell Death Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-018-2287-5","article-title":"Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia","volume":"18","author":"Huang MY","year":"2018","unstructured":"Huang MY, Tu CE, Wang SC, et al.. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia. BMC Complement Altern Med. 2018, 18:221. 10.1186\/s12906-018-2287-5","journal-title":"BMC Complement Altern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00320","article-title":"Targeting NLRP3 inflammasome in the treatment of CNS diseases","volume":"11","author":"Shao BZ","year":"2018","unstructured":"Shao BZ, Cao Q, Liu C. Targeting NLRP3 inflammasome in the treatment of CNS diseases. Front Mol Neurosci. 2018, 11:320. 10.3389\/fnmol.2018.00320","journal-title":"Front Mol Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/53897-no-nlrp3-inflammasome-expression-in-the-ouabain-animal-model-of-bipolar-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:47Z","timestamp":1707507707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/53897-no-nlrp3-inflammasome-expression-in-the-ouabain-animal-model-of-bipolar-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.24765","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,5]]}}}